SBFMSunshine Biopharma Inc.vs its industry peers
A metric-by-metric comparison of Sunshine Biopharma Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SBFM본 종목 | $4M#8 | 0.2x#1 | 0.1x#1 | 0.1x#1 | 4.1%#3 | -16.4%#6 | -17.2%#1 | -21.7%#2 | -63.1%#1 | — | -93.0%#3 | — |
| PULM | $5M#3 | — | 2.1x#7 | 0.7x#2 | 7.0%#2 | 46.0%#3 | -66.2%#2 | -201.9%#4 | -235.7%#2 | — | — | — |
| PCSA | $5M#4 | 2.9x#2 | — | — | — | 214.5%#1 | — | — | — | — | — | 0.8%#1 |
| LABT | $5M#5 | — | 1.2x#5 | — | — | — | — | 0.0%#1 | — | — | — | — |
| PRPH | $6M#2 | — | — | 1.3x#3 | -35.8%#4 | 72.4%#2 | -415.4%#4 | — | -804.6%#4 | — | — | — |
| DRMA | $5M#6 | — | 1.3x#6 | — | — | 38.5%#4 | — | -216.7%#6 | — | — | — | — |
| RVPH | $5M#7 | — | 0.3x#2 | — | — | 33.6%#5 | — | -130.6%#3 | — | — | -95.9%#4 | — |
| INM | $7M#1 | — | 6.6x#8 | 1.4x#4 | 7.5%#1 | -53.9%#9 | -160.8%#3 | -1168.4%#8 | — | — | -38.9%#1 | — |
| CVKD | $4M#9 | — | 1.0x#4 | — | — | -24.3%#7 | — | -323.5%#7 | -585.1%#3 | — | -91.7%#2 | — |
| BIVIW | $4M#10 | — | 0.4x#3 | — | — | -25.8%#8 | — | -214.9%#5 | -1671.2%#5 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice